Vuzix M400 smart glasses begin use case in Japan for ambulance emergency medical care

Goal is to provide early treatment and improve outcomes for transported emergency patients

ROCHESTER, NY, August 16, 2022 Vuzix® Corporation (NASDAQ: VUZI), (“Vuzix” or the “Company”), a leading provider of smart glasses and augmented reality (AR) technologies and products, today announced that its M400 smart glasses are currently being tested in Japan for an emergency medical care plan to provide early treatment with the goal of improving patient outcomes and rescue rates for critically ill patients transported to hospital. The collaborative effort on this trial involves Juntendo University, Shizuoka Hospital, Shunto Izu Fire Department, and AVR Japan Co., Ltd.

In this trial, emergency medical technicians (paramedics) use Vuzix M400 smart glasses to transmit medical information from the ambulance to the hospital, from the time of patient engagement until delivery to the hospital . Previously, the only means of communication between rescuers and doctors waiting in the hospital was via mobile phone calls, and information sharing was voice-only. By using smart glasses with two-way audio and video communications, it becomes possible to share medical information such as vital signs and ECG readings, as well as the patient’s facial expressions and other visual changes in status, by real time with the doctors and nurses who are waiting at the hospital where they are transported.

By sharing this real-time information with the hospital, it is expected that examinations, diagnoses and preliminary medical treatment decisions can be made by different departments in the hospital even before the patient arrives. In addition, hospital doctors can better instruct accurate emergency treatment in transit (blood transfusion, surgery, thrombolytic therapy, intravascular treatment, etc.) for urgent diseases such as cardiovascular diseases.

Currently, Vuzix smart glasses are used by some ambulances under the jurisdiction of the Shunto Izu Fire Department. In the future, there are plans to expand the trial to include more ambulances to continue research into the effectiveness of using smart glasses.

“Among their growing uses in healthcare, Vuzix smart glasses can be an important life support tool for paramedics who require critical interaction and support from the hospitals they are traveling to,” said Paul Travers, President and CEO of Vuzix. “Our goggles are lightweight, comfortable and completely wireless, making them ideal for use with other head-mounted equipment that paramedics need to wear. We look forward to seeing an expansion of this trial by its participants, as well that the adoption of a similar use by other providers in Japan and all over the world.”

About Vuzix Corporation

Vuzix is ​​a leading provider of smart eyewear and augmented reality (AR) technologies and products for the consumer and enterprise markets. The Company’s products include personal displays and portable computing devices that provide users with a high-quality portable viewing experience, provide solutions for mobility, portable displays and augmented reality. Vuzix holds 247 patents and patents pending and numerous IP licenses in the field of video eyewear. The company has won innovation awards at the Consumer Electronics Show (or CES) for the years 2005 to 2022 and several wireless technology innovation awards, among others. Founded in 1997, Vuzix is ​​a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, United Kingdomand Tokyo, Japan. For more information, visit the Vuzix website, Twitter and Facebook pages.

Disclaimer of Forward-Looking Statements

Certain statements contained in this press release are “forward-looking statements” within the meaning of the Securities Litigation Reform Act of 1995 and applicable Canadian securities laws. Forward-looking statements in this release relate to Vuzix smart glasses, pending certifications of this use case, our current and future business relationships and opportunities with Juntendo University, Shizuoka Hospital, Shunto Izu and AVR Japan, and among other things the company’s leadership in the smart glasses and AR display industry. They are usually identified by words such as “believes”, “may”, “expects”, “anticipates”, “should” and similar expressions. Readers should not place undue reliance on these forward-looking statements, which are based on the Company’s beliefs and assumptions as of the date of this release. The Company’s actual results could differ materially due to risk factors and other matters described in more detail in the “Risk Factors” section of the Company’s annual reports and MD&A filed with the Securities and Exchange. United States Commission and applicable Canadian securities regulators (copies of which may be obtained at www.sedar.com Where www.sec.gov). Subsequent events and developments may cause these forward-looking statements to change. The Company specifically disclaims any obligation or intention to update or revise these forward-looking statements as a result of changes in events or circumstances after the date of this release, except as required by applicable law.

Media Contact and Investor Relations:

Ed McGregorInvestor Relations Director
Vuzix Company
[email protected]
Tel: (585) 359-5985

Vuzix Corporation, 25 Hendrix Road, West Henrietta, NY 14586 United States,
Investor Information – [email protected] www.vuzix.com

SOURCEVuzix Corporation

About John Tuttle

Check Also

New FDA draft guidelines aim to protect children participating in clinical trials

SILVER SPRING, MD., September 23, 2022 /PRNewswire/ — Today, the United States Food and Drug …